Zydelig® (idelalisib) Tablets for Relapsed CLL, FL, and SLL

What Zydelig® Is and How It Works

Zydelig® (idelalisib) is an oral PI3K-δ inhibitor used in certain relapsed blood cancers, including chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and small lymphocytic lymphoma (SLL). It is taken as tablets. Many people look for a Zydelig online purchase to access Canadian pricing, and some compare Zydelig without insurance options before ordering.

YouDrugstore is a licensed Canadian pharmacy headquartered in Manitoba; prescriptions are reviewed by licensed pharmacists before dispensing.

We source authentic brands through licensed, vetted partner pharmacies worldwide, offering a broad selection at competitive Canadian prices.

Idelalisib blocks the delta isoform of phosphoinositide 3-kinase (PI3K-δ), a signaling pathway that helps malignant B cells survive and proliferate. By inhibiting PI3K-δ, Zydelig reduces tumor cell growth and can shrink enlarged nodes and spleen size. In CLL, it may be used with an anti-CD20 antibody such as rituximab. In FL or SLL, it may be used after prior therapies. Follow your prescriber’s advice on whether Zydelig fits your treatment plan.

Dosage and Usage

• Standard adult dose: 150 mg by mouth twice daily.
• Swallow tablets whole with water; do not crush or split.
• You may take with or without food; try to take doses 12 hours apart.
• If you miss a dose, take the next dose at the usual time. Do not double.
• If you vomit after a dose, do not retake; take the next dose as scheduled.
• Your prescriber may reduce to 100 mg twice daily or interrupt treatment for side effects or lab abnormalities.
• Avoid grapefruit or Seville oranges and discuss all medicines, including herbals. Strong CYP3A inducers or inhibitors may affect idelalisib levels.
• Your care team will monitor liver tests, blood counts, and signs of infection during therapy.

• Store at 20–25 °C (68–77 °F); excursions 15–30 °C (59–86 °F).
• Keep tablets in the original, tightly closed container; protect from moisture.
• Keep out of reach of children and pets.
• When traveling, carry your medication in your hand luggage with the pharmacy label.
• Avoid leaving tablets in a hot car or near heat sources; do not freeze.
• Bring enough tablets for your trip plus a few extra days in case of delays.

Benefits and Savings

Zydelig can deliver meaningful responses in relapsed CLL, FL, and SLL. Many patients see reductions in lymph node size and symptom relief as treatment continues. Tablets are taken at home, which avoids infusion time and can simplify schedules compared with IV regimens.

Ordering from YouDrugstore offers access to Canadian pricing. Typical savings range from 60–80% versus many US retail prices, which can help with Zydelig tablets cost. This can be important for those paying a Zydelig cash price or exploring Zydelig without insurance options. Multi-month supplies may reduce the per-month cost, subject to your prescription.

For current promotions, see our Zydelig coupon page for potential seasonal offers.

Side Effects and Safety

• Diarrhea or colitis
• Nausea, vomiting, abdominal pain
• Fatigue, fever, cough
• Rash or itching
• Decreased appetite, weight loss
• Joint or muscle pain
• Infections, including upper respiratory infections
• Lab changes: elevated liver enzymes (ALT/AST), neutropenia

Serious risks can include severe hepatotoxicity, severe diarrhea/colitis, non-infectious pneumonitis, serious or opportunistic infections (including Pneumocystis jirovecii pneumonia and cytomegalovirus reactivation), intestinal perforation, and severe skin reactions. Your team may recommend infection prophylaxis and regular monitoring. The risk of hypoglycemia increases mainly when other drugs like insulin or sulfonylureas are part of your regimen; dose adjustments of those agents may be needed.

Onset Time

Pharmacokinetic steady state is usually reached within about one week of twice-daily dosing. Clinical changes vary by condition. Some people notice symptomatic improvement in weeks as lymph nodes shrink and energy improves. Objective responses in CLL, FL, or SLL are typically assessed over the first 1–3 months. Your clinician will review scan results, blood counts, and symptoms to gauge treatment benefit.

Compare With Alternatives

BTK inhibitors such as ibrutinib or acalabrutinib are oral options used in CLL and SLL. They block a different B-cell pathway and can be used in earlier or later lines of therapy depending on prior treatments and tolerance. Adverse effect profiles differ, including bleeding, cardiac, or hypertension considerations with some BTK inhibitors.

Venetoclax is a BCL-2 inhibitor used in CLL and some lymphomas, often combined with anti-CD20 antibodies. It can achieve deep remissions but requires a gradual dose ramp and monitoring for tumor lysis risk in higher-burden disease. Your oncology team will weigh idelalisib against these choices based on efficacy, toxicity profile, prior therapies, and comorbidities.

Rituximab and other anti-CD20 monoclonal antibodies may be used in combination regimens or as single agents in selected scenarios. Infusion schedules, premedication needs, and clinic time differ from oral-only approaches like Zydelig.

Combination Therapy

• CLL: Zydelig may be paired with rituximab; monitoring for infections and liver toxicity is essential.
• Anti-infective prophylaxis: Your team may prescribe agents to prevent Pneumocystis jirovecii pneumonia; antiviral monitoring may be advised.
• Glucose-lowering drugs: If used with insulin or sulfonylureas, clinicians may adjust those doses to reduce hypoglycemia risk.
• Drug interactions: Review all medications; strong CYP3A modifiers may require changes to avoid altered idelalisib exposure.

Patient Suitability and Cost-Saving Tips

Zydelig is intended for adults with certain relapsed B-cell malignancies. It may not be appropriate if you have uncontrolled active infections, significant liver inflammation, a history of severe colitis on similar agents, or severe pulmonary inflammation. Your team may screen for hepatitis B and review vaccination plans before starting. Avoid live vaccines during treatment.

Pregnancy and breastfeeding require special consideration due to potential harm to the fetus or infant. Use effective contraception as directed by your care team. People with moderate to severe hepatic impairment or very low neutrophil counts need careful evaluation and monitoring if treated.

To manage costs, consider a multi-month supply if approved on your prescription. This can lower the per-month price compared with smaller fills and can help if you are comparing a Zydelig out of pocket cost or Zydelig no insurance route. You can set gentle reorder reminders in your account so you do not run short between refills.

Authoritative Sources

FDA Prescribing Information for Zydelig (idelalisib)

Health Canada Drug Product Database: Zydelig (idelalisib)

Manufacturer Product Page: Zydelig (idelalisib)

Order Zydelig® from YouDrugstore: add to cart, upload your prescription, and we ship with prompt, express, cold-chain handling.

This content is educational and does not replace advice from your healthcare professional. Always follow your prescriber’s instructions for your situation.